Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

Long Live! Eagles Center Jason Kelce Retires After 13 NFL Seasons

Time for Kylie to get that cat?

Supreme Court Restores Trump to Ballot, Overriding State Attempts For Ban

The U.S. Supreme Court unanimously decided Monday to restore former president Donald Trump to 2024 presidential primary ballots. The court Monday rejected state attempts to hold the Republican former president accountable for the Capitol riot.

These Are the Absolute Best Destinations for Spring Break Camping

With warmer days and holidays ahead, it’s time to start planning.

JetBlue and Spirit End Merger Plan — Leaving Customers Dispirited and Blue

JetBlue and Spirit Airlines are ending their proposed $3.8 billion merger after a federal judge blocked the deal, ruling it would hurt competition.

Forget Timothée and Zendaya: Dune Is All About Supply-Chain Issues

The collapse of our own global economy as explained by "Dune."

Voyager Ventures Has Confidence Sustainable Tech Is Just Better

Voyager Ventures founding partners Sarah Sclarsic and Sierra Peterson discuss how they choose products and companies to invest in, and why there’s such high demand for sustainable tech.

Turning Ocean Waves Into Clean Energy

Inna Braverman, co-founder of Eco Wave Power, shares how her company’s tech works, plus the role governments should play in adopting clean energy.

🎶 It's the Most Wonderful Time of the Year🎶: IRS Launches Crackdown on Wealthy ‘non-filers’

You can run but you can't hide.

Spot Bitcoin ETFs Are Riding the Crypto Rally

Grayscale’s global head of ETFs Dave LaValle talks demand for the company’s spot Bitcoin ETF, the expected approval of Ethereum ETFs, and more.

One-on-One with Cronos Group’s CEO

Cronos CEO Mike Gorenstein explains the company’s latest quarterly results and plans for the future as cannabis becomes more widely accepted.

Load More